Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flinn

Showing results (771-780 of 1,037) with videos related to

Pageof 104
Sort By:
Blood|June 26, 2004
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemiaThomas S Lin, Ian W Flinn, Rama Modali, et al.
Journal of Agricultural and Food Chemistry|March 24, 2026
Inward Rectifier Potassium (Kir) Channel Inhibitors Protect Citrus from the Asian Citrus Psyllid by Inducing Toxicity and Inhibition of FeedingFlinn O'Hara, Alexandra Cremades, Na Xie, et al.
American Journal of Medical Genetics|March 1, 1985
Genetic amniocentesis: a twelve years' experienceJ V Dacus, R S Wilroy, R L Summitt, et al.
Journal of Vascular Surgery|September 1, 1988
Factors affecting the patency of infrainguinal bypassR B Rutherford, D N Jones, S E Bergentz, et al.
Surgery|December 1, 1982
Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstructionJ J Bergan, F J Veith, V M Bernhard, et al.
British Journal of Haematology|August 23, 2014
Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR(™) therapeutic protein, for relapsed or refractory NHL patientsJohn M Pagel, Stephen E Spurgeon, John C Byrd, et al.
Veterinary Ophthalmology|December 20, 2014
Effect of topical ophthalmic dorzolamide(2%)-timolol(0.5%) solution and ointment on intraocular pressure in normal horsesKyle L Tofflemire, Elizabeth M Whitley, Allison M Flinn, et al.
Transplantation and Cellular Therapy|October 28, 2023
Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20<sup>+</sup> B Cell LymphomaJavier Munoz, Ian W Flinn, Jonathon B Cohen, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 22, 2023
Radiofrequency Ablation-Induced Tumor Growth Is Suppressed by MicroRNA-21 Inhibition in Murine Models of Intrahepatic Colorectal CarcinomaLukas Salvermoser, S Nahum Goldberg, Flinn Laville, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Pageof 104

Showing results (771-780 of 1,037) with videos related to

Sort By:
Pageof 104
Blood|June 26, 2004
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemiaThomas S Lin, Ian W Flinn, Rama Modali, et al.
Journal of Agricultural and Food Chemistry|March 24, 2026
Inward Rectifier Potassium (Kir) Channel Inhibitors Protect Citrus from the Asian Citrus Psyllid by Inducing Toxicity and Inhibition of FeedingFlinn O'Hara, Alexandra Cremades, Na Xie, et al.
American Journal of Medical Genetics|March 1, 1985
Genetic amniocentesis: a twelve years' experienceJ V Dacus, R S Wilroy, R L Summitt, et al.
Journal of Vascular Surgery|September 1, 1988
Factors affecting the patency of infrainguinal bypassR B Rutherford, D N Jones, S E Bergentz, et al.
Surgery|December 1, 1982
Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstructionJ J Bergan, F J Veith, V M Bernhard, et al.
British Journal of Haematology|August 23, 2014
Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR(™) therapeutic protein, for relapsed or refractory NHL patientsJohn M Pagel, Stephen E Spurgeon, John C Byrd, et al.
Veterinary Ophthalmology|December 20, 2014
Effect of topical ophthalmic dorzolamide(2%)-timolol(0.5%) solution and ointment on intraocular pressure in normal horsesKyle L Tofflemire, Elizabeth M Whitley, Allison M Flinn, et al.
Transplantation and Cellular Therapy|October 28, 2023
Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20<sup>+</sup> B Cell LymphomaJavier Munoz, Ian W Flinn, Jonathon B Cohen, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 22, 2023
Radiofrequency Ablation-Induced Tumor Growth Is Suppressed by MicroRNA-21 Inhibition in Murine Models of Intrahepatic Colorectal CarcinomaLukas Salvermoser, S Nahum Goldberg, Flinn Laville, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Pageof 104